In depth: Has the US succeeded in its OTC reforms?

risk0114-g20-indepth-butterfly-marklong

Those involved in the US derivatives market were likely to have ended 2013 breathing a deep sigh of relief, and congratulating themselves on making it through an extraordinary 12 months of regul